Investigating how the end of SARS-CoV-2 RNA affects COVID-19 severity in obese individuals
The Untranslated 3'End of SARS-CoV-2 RNA as a Determinant of Obesity-Accelerated Infectivity
This study is looking at how being obese might affect how easily the COVID-19 virus can infect people, and it hopes to find new ways to help treat those who are at greater risk because of their weight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10689137 on NIH RePORTER |
What this research studies
This research focuses on understanding the relationship between obesity and the infectivity of SARS-CoV-2, the virus responsible for COVID-19. It aims to explore how the untranslated 3' end of the virus's RNA may influence its ability to infect individuals, particularly those who are obese. By examining the molecular mechanisms involved, the study seeks to identify potential therapeutic targets that could lead to improved antiviral treatments for patients who are at higher risk due to obesity. The research employs advanced biological assays to analyze the interactions between viral RNA and host cellular machinery.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are obese and may be at increased risk for severe COVID-19.
Not a fit: Patients who are not obese or those who do not have a risk of COVID-19 infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral therapies specifically tailored for obese patients, improving their treatment outcomes for COVID-19.
How similar studies have performed: While the specific focus on the 3' end of SARS-CoV-2 RNA in relation to obesity is novel, similar research has shown that understanding viral mechanisms can lead to successful therapeutic advancements.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Fox, Paul L — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Fox, Paul L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.